Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             41 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse Raffaghello, L.
2003
197 1-2 p. 205-209
5 p.
artikel
2 Apoptosis pathways in neuroblastoma therapy Fulda, Simone
2003
197 1-2 p. 131-135
5 p.
artikel
3 Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells De Preter, Katleen
2003
197 1-2 p. 53-61
9 p.
artikel
4 A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors Ross, Robert A.
2003
197 1-2 p. 35-39
5 p.
artikel
5 Author Index 2003
197 1-2 p. 239-240
2 p.
artikel
6 Biological and clinical role of p73 in neuroblastoma Romani, M.
2003
197 1-2 p. 111-117
7 p.
artikel
7 Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany Schilling, Freimut H
2003
197 1-2 p. 19-28
10 p.
artikel
8 der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) – detected by spectral karyotyping (SKY) Stark, Batia
2003
197 1-2 p. 75-79
5 p.
artikel
9 Development of Fab′ fragments of anti-GD2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma Brignole, Chiara
2003
197 1-2 p. 199-204
6 p.
artikel
10 Disseminated tumor cells in the bone marrow – chances and consequences of microscopical detection methods Ambrosa, Peter F.
2003
197 1-2 p. 29-34
6 p.
artikel
11 Editorial Board 2003
197 1-2 p. ii-
1 p.
artikel
12 Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma Mora, Jaume
2003
197 1-2 p. 119-124
6 p.
artikel
13 Familial neuroblastoma: a complex heritable disease Tonini, Gian Paolo
2003
197 1-2 p. 41-45
5 p.
artikel
14 Fenretinide as an anti-angiogenic agent in neuroblastoma Ribatti, Domenico
2003
197 1-2 p. 181-184
4 p.
artikel
15 Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? Scott, Debbie
2003
197 1-2 p. 81-86
6 p.
artikel
16 Genetic and epigenetic alterations in neuroblastoma Tonini, Gian Paolo
2003
197 1-2 p. 69-73
5 p.
artikel
17 Hypoxia-induced dedifferentiation in neuroblastoma cells Jögi, Annika
2003
197 1-2 p. 145-150
6 p.
artikel
18 Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma Raffaghello, L.
2003
197 1-2 p. 151-155
5 p.
artikel
19 Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma Lovat, Penny E.
2003
197 1-2 p. 157-163
7 p.
artikel
20 Instructions to Authors 2003
197 1-2 p. 257-259
3 p.
artikel
21 Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age Berthold, F
2003
197 1-2 p. 11-17
7 p.
artikel
22 Negative autoregulation of p73 and p53 by ΔNp73 in regulating differentiation and survival of human neuroblastoma cells Nakagawa, Takahito
2003
197 1-2 p. 105-109
5 p.
artikel
23 Neuroblastoma – a developmental perspective McConville, Carmel M
2003
197 1-2 p. 3-9
7 p.
artikel
24 Neuroblastoma – developmental and molecular biology meet therapy design Schwab, Manfred
2003
197 1-2 p. 1-
1 p.
artikel
25 Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase Jikai, J.
2003
197 1-2 p. 219-224
6 p.
artikel
26 Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma Ohira, Miki
2003
197 1-2 p. 63-68
6 p.
artikel
27 Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma Lange, B
2003
197 1-2 p. 225-230
6 p.
artikel
28 Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments Bestagno, Marco
2003
197 1-2 p. 193-198
6 p.
artikel
29 Retinoid therapy of high-risk neuroblastoma Reynolds, C.Patrick
2003
197 1-2 p. 185-192
8 p.
artikel
30 Subject Index 2003
197 1-2 p. 241-255
15 p.
artikel
31 Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment Brignole, Chiara
2003
197 1-2 p. 231-235
5 p.
artikel
32 Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma Yang, Xuezhong
2003
197 1-2 p. 137-143
7 p.
artikel
33 The MYCN oncoprotein as a drug development target Lu, Xiaohong
2003
197 1-2 p. 125-130
6 p.
artikel
34 The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis van Noesel, Max M.
2003
197 1-2 p. 165-172
8 p.
artikel
35 The p53 pathway and its inactivation in neuroblastoma Tweddle, Deborah A.
2003
197 1-2 p. 93-98
6 p.
artikel
36 The regulation of angiogenesis in neuroblastoma Chlenski, Alexandre
2003
197 1-2 p. 47-52
6 p.
artikel
37 The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification Hogarty, Michael D.
2003
197 1-2 p. 173-179
7 p.
artikel
38 The role of the MEIS homeobox genes in neuroblastoma Geerts, Dirk
2003
197 1-2 p. 87-92
6 p.
artikel
39 Vaccination with minigenes encoding for novel ‘self’ antigens are effective in DNA-vaccination against neuroblastoma Huebener, N.
2003
197 1-2 p. 211-217
7 p.
artikel
40 Volume Contents 2003
197 1-2 p. 237-238
2 p.
artikel
41 When p53 needs p73 to be functional – forced p73 expression induces nuclear accumulation of endogenous p53 protein Goldschneider, David
2003
197 1-2 p. 99-103
5 p.
artikel
                             41 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland